Suppr超能文献

抗炎药物与实验性支气管炎

Anti-inflammatory drugs and experimental bronchitis.

作者信息

Jeffery P K

出版信息

Eur J Respir Dis Suppl. 1986;146:245-57.

PMID:3536552
Abstract

Chronic bronchitis (chronic hypersecretion) and chronic bronchiolitis (small airways disease) are two conditions associated with cigarette smoking: both contribute to airflow obstruction in man, the latter associated with progressive deterioration in lung function. Mucous metaplasia and hyperplasia are characteristic histological changes. Experimentally, cigarette smoke given daily for two weeks, induces similar histological changes in the airways of specific pathogen-free rats, providing a suitable animal model for study: an early proliferation of basal cells, accompanied by mucous metaplasia of surface epithelial serous cells is followed by proliferation of newly formed mucous cells. There is also a significant increase in epithelial thickness due to cell hypertrophy without stratification or prior ulceration. Experimentally, secretory cell hyperplasia is inhibited completely or to varying degrees by prophylactic administration (intraperitoneal injection) of either indomethacin, flurbiprofen, dexamethasone, prednisolone, hydrocortisone (each at 2 or 4 mg/kg body weight) or a mucolytic drug, N-acetylcysteine(Nac), given orally as a 1% solution of the drinking water. Nac also inhibits the associated mucus-hypersecretion. It takes between 21 and 84 days, depending on airway level, for the increase in secretory cell number to return to control values (ie recover). Indomethacin and flurbiprofen (4 mg/kg, by ip injection) shorten recovery to between 4 and 9 days in intrapulmonary airways but have no effect on recovery time in the rat trachea. Nac is effective in 6 of 7 airway levels which showed cigarette smoke-induced mucous cell hyperplasia. In conclusion, in the rat, the response to cigarette smoke is one of mucous cell metaplasia and both basal and mucous cell proliferation. Cigarette smoke-induced mucous cell hyperplasia can be inhibited when selected drugs are given concurrently with the cigarette smoke: indomethacin, fluriprofen and Nac are also therapeutic.

摘要

慢性支气管炎(慢性分泌亢进)和慢性细支气管炎(小气道疾病)是与吸烟相关的两种病症:二者均会导致人体气流阻塞,后者还与肺功能的进行性恶化有关。黏液化生和增生是典型的组织学变化。在实验中,给无特定病原体的大鼠每日吸入香烟烟雾两周,可在其气道中诱导出类似的组织学变化,从而提供了一个合适的研究动物模型:基底细胞早期增殖,伴有表面上皮浆液细胞的黏液化生,随后是新形成的黏液细胞增殖。由于细胞肥大,上皮厚度也显著增加,但无分层或先前溃疡现象。在实验中,通过预防性给药(腹腔注射)吲哚美辛、氟比洛芬、地塞米松、泼尼松龙、氢化可的松(均为2或4毫克/千克体重)或口服作为1%饮用水溶液的黏液溶解药物N-乙酰半胱氨酸(Nac),可完全或不同程度地抑制分泌细胞增生。Nac还可抑制相关的黏液分泌亢进。根据气道水平不同,分泌细胞数量增加恢复至对照值(即恢复)需要21至84天。吲哚美辛和氟比洛芬(4毫克/千克,腹腔注射)可将肺内气道的恢复时间缩短至4至9天,但对大鼠气管的恢复时间无影响。Nac对7个气道水平中的6个有效,这些气道水平出现了香烟烟雾诱导的黏液细胞增生。总之,在大鼠中,对香烟烟雾的反应是黏液细胞化生以及基底细胞和黏液细胞增殖。当与香烟烟雾同时给予选定药物时,香烟烟雾诱导的黏液细胞增生可被抑制:吲哚美辛、氟比洛芬和Nac也具有治疗作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验